Selexis Announces Expansion of R&D License Agreement with Amgen

News   Feb 22, 2013

 
Selexis Announces Expansion of R&D License Agreement with Amgen
 
 
 

RELATED ARTICLES

Malvern Panalytical Wins Innovate UK Grant

News

Funding for 3-year-long project to lead biopharmaceutical consortium on aggregation analytics.

READ MORE

SYGNIS AG Signs Supply Agreement with US Biological for the Lightning-Link Antibody Labelling Technology

News

SYGNIS AG, the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, announced it has signed a supply agreement with US Biological, Salem, MA, USA, for its Innova Lightning-Link® technology.

READ MORE

Novel Artificial Photosynthesis Device for Greener Ethylene Production

News

A team of scientists from the National University of Singapore (NUS) has developed a prototype device that mimics natural photosynthesis to produce ethylene gas using only sunlight, water and carbon dioxide.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE